Societe Generale Effekten (S30613) Quote

As much as Phil'lippers want to cover their eyes & ears on this assessment they know what we we all know that your spot on w/ your assessment.

Junk stocks every one...

Unfortunately, it is those very emotions surrounding a diagnosis of cancer, that is used by some to attempt to sell a product, whose efficacy doesn't quite match the price point.

Sure there are stepping stones in the development of new treatments, but do not get there by massively ove

If it were true that it will take one more year for the MHRA to validate
the utilization of the Flaskworks, it will also take the same amount of
time before NWBO can submit a BLA to the FDA because IMHO
the validation of the Flaskworks is a prerequisite for the BLA.

Nah. I really don't think anyone's sweating about GME.

The only place that you will find a bed count in a filing for this treatment center is in the regulation "A" offering prospectus last amended October 2023. Up to a potential of 52 beds is all that we know for certain. Initially in the FAQ page for July 2021 they claimed that they would have 54 beds

Let’s face facts if we still hold we will lose more money make your decision.

Explain why it is not sustainable.

Well yeah it did pop to 4.76 but that's not sustainable.

Give details please.

TIA.

$AMC baby~!

16:00:01 Is a buy

By the way. Cash Position: As of March 31, 2024, cash and cash equivalents totaled $48.9 million.
Co is losing about $20m a Qt running this trial ....so expect an immediate cash raise ...or warrant holders exercising some of their warrants if stock really pops on results .
Either way

https://scontent-lax3-2.xx.fbcdn.net/v/t39.30808-6/448984954_10226340862447735_4966858942583752611_n.jpg?_nc_cat=100&ccb=1-7&_nc_sid=5f2048&_nc_ohc=blW7IUrx7h0Q7kNvgGWL_wg&_nc_ht=scontent-lax3-2.xx&oh=00_AYD8iZw8M-iQRWazAAkD5bjYdv2RQazvezy4wrkFfw67DQ&oe=667CD50A

https://scontent-lax3-

OS is locked?!

BBW sends me private nasty messages I guess he can't make it public lol

You call yourself a skeptic. We all know that’s garbage. You are a paid basher.

You here to start trouble Marcus.

It’s amazing how you can find 1 million red flags about this company but not one good reason for them to be in existence. Even though they’ve had a successful phase 3 trial in are about to have their Drug approved. All you see is gloom and. Doom

The fud basher video the CEO has been referring to is reposted on YouTube, after removing any copyright concerns (showing their website). It's titled "AITX Called This Bashing & Fud, You Decide"

says sell?

JHD

You also need to be a share holder.

I think tens of billions of dollars is the right range for blarcamesine.

The article assigned a Aducanumab value to Biogen (53.2% profit split) of $10.6 billion as a Phase III drug prior to approval. AVXL's market cap is $0.345 billion. It's hard to believe the market's valuation di

Like I always say and said it the other day. Up 5% take profit. What just happened? It was up 5% for about what 5 minutes haha. By the time I get alerts that tell me it's up 5% it's already usually sold off. Drive be from my house to the gym and all profit gone already

Good, one reason we purchased 4 in the last 15 plus years...